Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688198's PB Ratio is ranked worse than 87.91% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2
vs SHSE:688198: 7.81
During the past 12 months, Beijing Balance Medical Technology Co's average Book Value Per Share Growth Rate was 6.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 5.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.70% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Beijing Balance Medical Technology Co was 82.80% per year. The lowest was 5.90% per year. And the median was 12.50% per year.
Back to Basics: PB Ratio
Beijing Balance Medical Technology Co (SHSE:688198) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Beijing Balance Medical Technology Co PB Ratio Related Terms
Beijing Balance Medical Technology Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Balance Medical Technology Co PB Ratio Chart
For the Medical Devices subindustry, Beijing Balance Medical Technology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Balance Medical Technology Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Balance Medical Technology Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Beijing Balance Medical Technology Co's PB Ratio falls into.
Beijing Balance Medical Technology Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Beijing Balance Medical Technology Co (SHSE:688198) has a PB Ratio of 7.81 as of Jul. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Beijing Balance Medical Technology Co and its competitors. This is 41% below median its historical median of 13.15. Over the past decade, Beijing Balance Medical Technology Co's PB Ratio has ranged from 5.26 to 29.79. According to the industry distribution chart, Beijing Balance Medical Technology Co ranks #691 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 87.9%.
Is Beijing Balance Medical Technology Co's PB Ratio too high?
Beijing Balance Medical Technology Co's current PB Ratio of 7.81 is 41% below median its 10-year median of 13.15. Over the past 10 years, this metric has ranged from a low of 5.26 to a high of 29.79. The Medical Devices & Instruments industry median PB Ratio is 2.00. Beijing Balance Medical Technology Co's value of 7.81 is 290.5% above this industry median. Based on the distribution chart, Beijing Balance Medical Technology Co ranks #691 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beijing Balance Medical Technology Co has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Balance Medical Technology Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Beijing Balance Medical Technology Co ranks #691 out of 786 companies for PB Ratio. This places Beijing Balance Medical Technology Co in the lower half of its industry. The industry median PB Ratio is 2.00. Beijing Balance Medical Technology Co's value of 7.81 is 290.5% above this benchmark. Historically, Beijing Balance Medical Technology Co's own PB Ratio has ranged from 5.26 to 29.79 over the past decade. While the company's 10-year median is 13.15 vs. the industry median of 2.00, Beijing Balance Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.00, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Balance Medical Technology Co's current PB Ratio of 7.81 is 290.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Beijing Balance Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Balance Medical Technology Co's current PB Ratio is 7.81, which is 41% below median its own 10-year median of 13.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Balance Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co (SHSE:688198) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥185.48, compared to a current price of ¥77.60 — trading 58.2% below its estimated fair value. The current PB Ratio is 7.81, which is 41% below median its 10-year median of 13.15 and 290.5% above the Medical Devices & Instruments industry median of 2.00. Beijing Balance Medical Technology Co's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Beijing Balance Medical Technology Co (SHSE:688198), the current PB Ratio is 7.81 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Balance Medical Technology Co (SHSE:688198) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co stock appears to be undervalued.
The current stock price of ¥77.60 is trading 58.2% below its estimated GF Value™ of ¥185.48.
GuruFocus considers Beijing Balance Medical Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688198:
PB Ratio: 7.81 (41% below median its 10-year median of 13.15)
GF Value™: ¥185.48 vs. price of ¥77.60 (58.2% below fair value)
Industry Position: 290.5% above the Medical Devices & Instruments median (#691 of 786)
No single metric tells the full story. See the SHSE:688198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Balance Medical Technology Co Business Description
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.
87GF Score
Get the complete analysis for SHSE:688198
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688198 has been successfully added to your 
